Premium
Regulators' Advice Can Make a Difference: European Medicines Agency Approval of Zynteglo for Beta Thalassemia
Author(s) -
SchuesslerLenz Martina,
Enzmann Harald,
Vamvakas Spiros
Publication year - 2020
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1639
Subject(s) - beta thalassemia , advice (programming) , agency (philosophy) , thalassemia , medicine , beta (programming language) , drug approval , pharmacology , family medicine , computer science , drug , sociology , social science , programming language